RA was well tolerated in the Phase I trial. Now MBX is planning a Phase II trial in post-bariatric hypoglycaemia patients.

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.

Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...

The following is a summary of “Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

PRNewswire/ -- (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today ...